Your Search Results

Personalised Vascular Care Award - Ceremony

20 May 2026 – From EuroPCR 2026

The Personalised Vascular Care Award Ceremony celebrated outstanding achievements in the advancement of personalized vascular treatment approaches, recognizing leaders who have contributed significantly to improving patient outcomes in vascular care.

EuroPCR 2026 Closing Ceremony

22 May 2026 – From EuroPCR 2026

The EuroPCR 2026 Closing Ceremony marks the conclusion of this premier cardiology event, celebrating the latest advances and achievements in interventional cardiology. It offers an opportunity to reflect on the educational sessions, network with peers, and recognize outstanding contributions to the field.

Welcome to EuroPCR 2026

19 May 2026 – From EuroPCR 2026

Welcome to EuroPCR 2026, the premier event for interventional cardiology professionals. This edition offers cutting-edge scientific presentations, live cases, and interactive sessions designed to advance knowledge and clinical practice in cardiovascular interventions.

Top Coronary Complication Cases

22 May 2026 – From EuroPCR 2026

A collection of challenging coronary complication cases is presented, including management of stuck wires in calcific CTOs, complex PCI scenarios with unexpected twists, techniques for puncturing seals, and dealing with microaxial pump kinks, providing valuable lessons in complication management during interventional procedures.

Cardiac dimensions receives Medical Device Regulation (MDR) certification for Carillon Mitral Contour System

25 Apr 2023

Mid-term echocardiographic outcomes following transapical mitral valve replacement: Updates from the Intrepid Pilot Study

19 Sep 2022

Pamela Gatto provides her take on the Intrepid Global Pilot Study which was presented by Renuka Jain at TCT Congress 2022.

Author

Pamela Gatto

Updates from the Intrepid Pilot Study: Mid-term Echocardiographic Outcomes Following Transapical Mitral Valve Replacement

RESHAPE-HF2 - Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure

01 Sep 2024

Nicola Ryan provides her take on the RESHAPE-HF2 trial presented by Stefan Anker at the ESC Congress 2024 in London and simultaneously published in the NEJM.

The RESHAPE-HF 2 trial is a prospective randomised control trial comparing transcatheter mitral valve repair (TEER) and guideline-directed medical therapy to guideline-directed medical...

Author

Nicola Ryan

Percutaneous coronary intervention of native coronary artery versus saphenous vein graft in patients with prior coronary artery bypass graft surgery (PROCTOR)

03 Nov 2025

Kalaivani Mahadevan and Trisha Singh provide their take on the PROCTOR study presented by Ruben de Winter at TCT 2025, in San Francisco.